Advanced search
Publication Cover
Journal of Asthma and Allergy Volume 15, 2022 - Issue
Submit an article Journal homepage
161
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Increase in FeNO Levels Following IL5/IL5R-Targeting Therapies in Severe Asthma: A Case Series

Geneviève Pelletier1 Quebec Heart and Lung Institute – Laval University, Quebec, QC, CanadaView further author information
,
Krystelle Godbout1 Quebec Heart and Lung Institute – Laval University, Quebec, QC, Canada;2 Department of Medicine, Faculty of Medicine, Laval University, Quebec, QC, CanadaView further author information
,
Marie-Ève Boulay1 Quebec Heart and Lung Institute – Laval University, Quebec, QC, CanadaView further author information
,
Louis-Philippe Boulet1 Quebec Heart and Lung Institute – Laval University, Quebec, QC, Canada;2 Department of Medicine, Faculty of Medicine, Laval University, Quebec, QC, CanadaView further author information
,
Mathieu C Morissette1 Quebec Heart and Lung Institute – Laval University, Quebec, QC, Canada;2 Department of Medicine, Faculty of Medicine, Laval University, Quebec, QC, CanadaView further author information
&
Andréanne Côté1 Quebec Heart and Lung Institute – Laval University, Quebec, QC, Canada;2 Department of Medicine, Faculty of Medicine, Laval University, Quebec, QC, CanadaCorrespondence[email protected]
View further author information
Pages 691-701 | Published online: 19 May 2022

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

C. Menigoz, S. Dirou, A. Chambellan, D. Hassoun, A. Moui, A. Magnan & F. X. Blanc. (2023) Use of FeNO to predict anti-IL-5 and IL-5R biologics efficacy in a real-world cohort of adults with severe eosinophilic asthma. Journal of Asthma 60:6, pages 1162-1170.
Read now

Articles from other publishers (4)

Fred Fyles, Amy Nuttall, Hannah Joplin & Hassan Burhan. (2023) Long-Term Real-World Outcomes of Mepolizumab and Benralizumab Among Biologic-Naive Patients With Severe Eosinophilic Asthma: Experience of 3 Years’ Therapy. The Journal of Allergy and Clinical Immunology: In Practice 11:9, pages 2715-2723.
Crossref
Tommaso Pianigiani, Lorenzo Alderighi, Martina Meocci, Maddalena Messina, Beatrice Perea, Simona Luzzi, Laura Bergantini, Miriana D’Alessandro, Rosa Metella Refini, Elena Bargagli & Paolo Cameli. (2023) Exploring the Interaction between Fractional Exhaled Nitric Oxide and Biologic Treatment in Severe Asthma: A Systematic Review. Antioxidants 12:2, pages 400.
Crossref
. (2022) Benralizumab/mepolizumab. Reactions Weekly 1937:1, pages 117-117.
Crossref
Zhuya Yang, Xiaohong Li, Rongbing Fu, Min Hu, Yijie Wei, Xuhong Hu, Wenhong Tan, Xiaoyun Tong & Feng Huang. (2022) Therapeutic Effect of Renifolin F on Airway Allergy in an Ovalbumin-Induced Asthma Mouse Model In Vivo. Molecules 27:12, pages 3789.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.